Singapore markets close in 25 minutes
Straits Times Index
3,301.28 -12.77 (-0.39%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,392.91 -31.29 (-0.37%) Bitcoin USD
70,974.76 +4,071.34 (+6.09%) CMC Crypto 200
1,525.44 +36.90 (+2.48%)
Rocket Pharmaceuticals, Inc. (RCKT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.07B |
| Enterprise value | 1.77B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.69 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.11 |
| 52-week change 3 | 2.65% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 32.53 |
| 52-week low 3 | 14.89 |
| 50-day moving average 3 | 24.65 |
| 200-day moving average 3 | 23.45 |
Share statistics
| Avg vol (3-month) 3 | 695.74k |
| Avg vol (10-day) 3 | 496.45k |
| Shares outstanding 5 | 90.78M |
| Implied shares outstanding 6 | 90.78M |
| Float 8 | 70.96M |
| % held by insiders 1 | 3.43% |
| % held by institutions 1 | 106.14% |
| Shares short (30 Apr 2024) 4 | 9.84M |
| Short ratio (30 Apr 2024) 4 | 14.06 |
| Short % of float (30 Apr 2024) 4 | 23.08% |
| Short % of shares outstanding (30 Apr 2024) 4 | 10.84% |
| Shares short (prior month 28 Mar 2024) 4 | 10.52M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 05 Jan 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:4 |
| Last split date 3 | 05 Jan 2018 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -32.64% |
| Return on equity (ttm) | -55.38% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -257.16M |
| Net income avi to common (ttm) | -249.31M |
| Diluted EPS (ttm) | -2.85 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 330.31M |
| Total cash per share (mrq) | 3.64 |
| Total debt (mrq) | 25.95M |
| Total debt/equity (mrq) | 5.88% |
| Current ratio (mrq) | 10.47 |
| Book value per share (mrq) | 4.87 |
Cash flow statement
| Operating cash flow (ttm) | -194.21M |
| Levered free cash flow (ttm) | -140.15M |
© 2024 Yahoo. All rights reserved.